Skip to main content
Premium Trial:

Request an Annual Quote

Expand the Network

With $161.3 million over the next five years, NIH plans to expand the Pharmacogenomics Research Network, the agency reports. The network had been working on linking genetic variants to cancer, heart disease, asthma, and among others and now will also include research into rheumatoid arthritis and bipolar disorder. The new awards include 14 research grants, with projects ranging from pharmacogenomics in rural areas ranging to the pharmacogenomics of mood stabilizers, as well as seven resource awards. Awardees include Kathleen Giacomini, Richard Gibbs, Deborah Nickerson, and Dan Roden.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.